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TRAF4 has previously been shown to activate JNK through an unknown
mechanism. Here, we show that endogenous TRAF4 and MEKK4 associ-
ate in both human K562 cells andmouse E10.5 embryos. TRAF4 interacts
with the kinase domain of MEKK4. However, this association does not
requireMEKK4kinase activity. The interaction ofMEKK4andTRAF4 are
further demonstrated by the colocalization of TRAF4 andMEKK4 in cells.
Importantly, although TRAF4 has little or no ability to activate JNK inde-
pendently, coexpression of TRAF4 andMEKK4 results in synergistic acti-
vation of JNK that is inhibited by a kinase-inactive mutant of MEKK4,
MEKK4K1361R. MEKK4 binds the TRAF domain of TRAF4 and MEKK4/
TRAF4 activation of JNK is inhibited by expression of the TRAF domain.
Furthermore, TRAF4 stimulates MEKK4 kinase activity by promoting
MEKK4 oligomerization and JNK activation can be stimulated by chemi-
cal induction of MEKK4 dimerization. The findings identify MEKK4 as
the MAPK kinase kinase for TRAF4 regulation of the JNK pathway.
MAP2 kinase (MAPK) pathways are critical regulators of numerous cellular
functions including cell proliferation, adhesion, migration, differentiation, and
apoptosis. MEKK4 is a 180-kDaMAPK kinase kinase (MAP3K) that phospho-
rylates and activates the MAPK kinases (MAP2K) MKK3, MKK4, MKK6, and
MKK7. MKK4 and MKK7 phosphorylate and activate the MAPK JNK,
whereas MKK3 and MKK6 phosphorylate and activate the MAPK p38. Both
the upstream signaling molecules and the biochemical mechanisms that reg-
ulate MEKK4 activation of JNK are poorly defined.
TRAF (TNF receptor-associated factor) family proteins play important roles
in development and immunity (1, 2). TRAF proteins function in part as scaf-
folds to organize signaling complexes coupled to specific receptors at the
plasmamembrane. There are six proteins inmammalian genomes that encode
TRAF domains near their C terminus that mediate oligomerization of TRAF
proteins and their association with specific membrane proteins. The N termi-
nus of TRAF proteins organize signaling complexes involved in the regulation
of MAPK and NF-B activation (2). Mice with targeted gene disruption of
TRAF2, -3, and -6 die shortly after birth, while disruption of the TRAF4 gene is
embryonic lethal (3, 4). TRAF4-deficient mouse embryos display impaired
neural tube closure defects and skeletal malformations similar to the
MEKK4K1361R knock-in mouse (4, 5).
TRAF4 is an atypical member of the TRAF family of proteins (1, 6). Its
expression is strongest during development suggesting an important role for
TRAF4 in the developing embryo (4, 7). Similar to TRAF4, MEKK4 is
expressed at low levels in adult tissues but is expressed strongly during devel-
opment (5, 8). TRAF4 has been shown to promote JNK activation, however the
signaling pathways leading to JNK activation have not been defined (9). There-
fore, we investigated the role of MEKK4 in TRAF4-mediated signaling. We
have discovered that TRAF4 is a binding partner forMEKK4. Their association
occurs through the kinase domain of MEKK4 and the TRAF domain of
TRAF4. TRAF4 increases MEKK4 kinase activity by promoting the oligomer-
ization of MEKK4 and enhances MEKK4 signaling to JNK.
MATERIALS AND METHODS
Cell Lines, Culture Conditions, andTransfections—K562 cells were cultured
in RPMI 1640 containing 10% fetal bovine serum, 1% penicillin and strepto-
mycin. E10.5 embryos were isolated from timed matings of 129 SvEv mice
according to university and federal guidelines for the use of animals. 293 cells
and COS-7 cells were cultured in Dulbecco’s modified Eagle’s high glucose
medium supplemented with 10% fetal bovine serum, 1% penicillin and strep-
tomycin. Transfections of 293 cells were performed in 60-mm dishes using
Lipofectamine Plus (Invitrogen) according to the manufacturer’s specifica-
tions for 24–36 h. COS-7 cells were plated on coverslips and transfected as
described for 293 cells.
Plasmids—Human TRAF4 cDNA was kindly provided by Nancy Raab-
Traub (University of North Carolina, Chapel Hill). HA tagged full-length
TRAF4 and the TRAF domain of TRAF4 (amino acids 308–470) in pCDNA3
were a kind gift from Dale Bredesen (Buck Center for Research in Aging). The
TRAF4N terminus (amino acids 1–307) and the TRAF4 Ring deletionmutant
(amino acids 58–470) in pCDNA3 were kindly given by Wafik El-Deiry
(Howard Hughes Medical Institute and University of Pennsylvania).
HA-tagged JNK, HA-tagged full-length MEKK4, and HA-tagged MEKK4
kinase domain (amino acids 1301–1597) were as described previously (10).
FLAG-tagged wild-type MEKK4 was constructed by subcloning MEKK4 into
FLAG-pCDNA3. The kinase-inactive MEKK4, MEKK4K1361R, was construct-
ing using PCR to replace the active site lysine with an arginine, producing a
kinase-inactive MEKK4 that was verified by sequencing. FK506-binding pro-
tein (FKBP) MEKK4 fusion constructs were created by introduction of SalI
sites on the wild-type MEKK4 kinase domain by PCR, and products were
subcloned into pSH1/SN-E-FV-FVls-E, a gift fromDavid Spencer (Baylor) con-
taining a point mutation Phe363 Val (FV) engineered in the FKBPs resulting
in 1000higher binding affinity of the synthetic dimerizerAP20187 compared
with the wild-type FKBP (11). Two FV sites were inserted on the N terminus of
the kinase domain of MEKK4 and a C-terminal HA tag.
Immunoprecipitations, Western Blot Analysis, Measurement of JNK Activ-
ity, and Kinase Assays—Cells were lysed in cold Buffer A containing 20 mM
Tris, pH 7.4, 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1% Triton-X, 1 mM
phenylmethylsulfonyl fluoride, 1mM sodium vanadate, 0.05mMdithiothreitol,
1 g/ml leupeptin, and 17 g/ml aprotinin. 500 g of lysate was immunopre-
cipitated for 1.5 h with the indicated antibodies, followed by incubation with
protein G-Sepharose (Zymed Laboratories Inc.) for 1.5 h. Immunoprecipitates
were washed four times with cold Buffer A. Lysates and immunoprecipitates
were probedwith anti-TRAF4 (Santa Cruz Biotechnology), anti-MEKK4, anti-
FLAG (Sigma), anti-HA (12CA5) and phosphospecific antibodies against
phospho-JNK (Cell Signaling). For kinase assays, lysates were prepared and
immunoprecipitated as described above. Immunoprecipitates were washed
three times with cold lysis buffer and once with cold kinase buffer containing
20 mM HEPES, pH 7.4, 10 mM MgCl2, 1 mM dithiothreitol, 0.1 mM sodium
vanadate, 10 mM -glycerphosphate, and 0.5 mM ATP. Reactions were incu-
bated with inactive His-MKK6 or GST-c-Jun at 30 °C for 20 min and probed
with anti-FLAG, anti-TRAF4, anti-HA, anti-phospho-c-Jun, and anti-phos-
pho-MKK3/6 (Cell Signaling) antibodies. Chemical dimerization experi-
ments using AP20187 provided by Ariad Pharmaceuticals (www.ariad.com/
regulationkits) were performed as described previously (11).
Immunofluorescence—For TRAF4 andMEKK4 staining, COS-7 cells plated
on coverslips were fixed for 10 mins in 3% paraformaldehyde containing 3%
sucrose and phosphate-buffered saline pH 7.4 and were permeabilized for 6
min in 0.1% Triton in phosphate-buffered saline. Coverslips were washed,
blocked in 10% donkey serum, and incubated for 1 h with murine anti-FLAG
and goat anti-TRAF antibodies diluted 1:500. Coverslips were washed and
incubated with DAPI (0.04 ng/ml), Cy3 donkey anti-goat diluted 1:500, and
fluorescein isothiocyanate donkey anti-mouse. Imaging was performed using
an Axiovert 200 M microscope from Zeiss. Imaging software from Intelligent
Imaging Innovations (Denver, Colorado) was used to perform nearest neigh-
bors deconvolution on 0.1-m sections.
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RESULTS AND DISCUSSION
TRAF4, an Atypical Embryonic TRAF, Binds MEKK4—Immunoprecipita-
tion assays using K562 cells that endogenously express high levels of both
TRAF4 and MEKK4 demonstrated that endogenous MEKK4 was specifically
coprecipitated with TRAF4 (Fig. 1A). Similarly, immunoprecipitation of
endogenous MEKK4 from K562 cells revealed an association of TRAF4 (data
not shown). Both TRAF4 andMEKK4 are expressed at low levels inmost adult
mouse tissues, whereas expression is strong throughout embryogenesis with
particularly high levels in the developing neuroepithelium (5, 7, 8). Signifi-
cantly, TRAF4 and MEKK4 coprecipitated in lysates prepared from E10.5
embryos showing the association of MEKK4 and TRAF4 during development
(Fig. 1B). These data demonstrate an in vivo association of TRAF4 andMEKK4
and suggests a role for this interaction in MEKK4 and TRAF4 function.
Analysis of TRAF4 and MEKK4 Interaction Domains—Analysis of the
domains of MEKK4 that bind full-length TRAF4 revealed that the N terminus
of MEKK4 did not bind TRAF4 (data not shown). The kinase domain alone of
MEKK4 was sufficient for the association of MEKK4 with TRAF4 (Fig. 2A).
However, binding of TRAF4 toMEKK4 was not dependent onMEKK4 kinase
activity as TRAF4 coimmunoprecipitated equallywith FLAG-taggedwild-type
MEKK4 or a kinase-inactive MEKK4 where the active site lysine is substituted
with an arginine (MEKK4K1361R) (Fig. 2B). The interaction domains of TRAF4
with full-length MEKK4 were similarly examined. In contrast to the N termi-
nus of TRAF4 that failed to bind MEKK4, the TRAF domain of TRAF4 was
necessary and sufficient for binding to MEKK4 (Fig. 2C). Consistent with the
lack of binding of MEKK4 to the N terminus of TRAF4, MEKK4 retained the
ability to bind a mutant TRAF4 wherein the RING domain in the N terminus
was deleted (Fig. 2C). Together, these data show the specific interaction of the
TRAF domain of TRAF4 with the kinase domain of MEKK4.
Colocalization of MEKK4 and TRAF4 in the Cytoplasm of COS-7 Cells—
Previous reports have yielded conflicting results regarding the localization of
TRAF4 within the cell. Some studies have shown a nuclear localization of
TRAF4, whereas others have shown that TRAF4 localizes specifically to the
cytoplasm (12, 13).MEKK4 has been shown to localize to the cytoplasm and to
perinuclear, Golgi-associated vesicles (14). To determine whether TRAF4 and
MEKK4 localized to similar regions within the cell, COS-7 cells were cotrans-
fected with TRAF4 and MEKK4, and the localization of these proteins was
examined by the immunofluroescence of deconvolved 0.1 M sections. As
shown in Fig. 3, MEKK4 and TRAF4 colocalized in the cytoplasm of COS-7
cells with pronounced staining in the perinuclear region of the cell. Immuno-
staining for TRAF4 and MEKK4 was not detected in the nuclei of cells as
assessed by lack of colocalization with the nuclear stain DAPI (Fig. 3). The
FIGURE 1. Association of endogenous TRAF4 and MEKK4. A, coprecipitation of endog-
enous MEKK4 with TRAF4 in K562 cells. Cells lysates (K562) or lysis buffer alone (C) was
incubated with either an anti-TRAF4 antibody or no antibody and imunoblotted with
antibodies to TRAF4 and MEKK4. MEKK4 specifically precipitated with TRAF4. B, copre-
cipitation of endogenous TRAF4 with MEKK4 from lysates prepared from E10.5 embryos.
Embryo lysates prepared from embryos isolated in timed matings were immunoprecipi-
tated with an anti-MEKK4 antibody and immunoblotted with antibodies to TRAF4 and
MEKK4. MEKK4 is highly sensitive to proteolysis. The lower bands represent cleavage
fragments of MEKK4.
FIGURE 2. TRAF4 binds to the kinase domain of MEKK4; however, this association
does not require MEKK4 kinase activity. A, the kinase domain of MEKK4 is sufficient for
the association of MEKK4 with TRAF4. 293 cells were transiently cotransfected with
TRAF4 and HA-tagged full-length MEKK4 or the kinase domain of MEKK4. Lysates were
immunoprecipitated with an anti-TRAF4 antibody and then probed with antibodies to
HA and TRAF4. B, coprecipitation of TRAF4 with MEKK4 does not require MEKK4 kinase
activity. 293 cells were transiently cotransfected with TRAF4 and FLAG-MEKK4wt or
kinase-inactive FLAG-MEKK4K1361R. Lysates were immunoprecipitated with an anti-
FLAG antibody and then probed with antibodies to FLAG and TRAF4. C, coprecipitation
of MEKK4 with the TRAF domain of TRAF4. 293 cells were transiently transfected with
FLAG-MEKK4 and full-length TRAF4, TRAF4 N terminus, TRAF4 TRAF domain, or a RING
deletion mutant of TRAF4. Lysates were immunoprecipitated as indicated with either an
anti-N-terminal or anti-C-terminal TRAF4 antibody and probed with antibodies to FLAG
and TRAF4. MEKK4 is highly sensitive to proteolysis. The lower bands represent cleavage
fragments of MEKK4. Full-length TRAF4 and the RING deletion mutant are sensitive to
proteolysis. Smaller bands represent cleavage fragments of TRAF4.
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colocalization of TRAF4 and MEKK4 is consistent with their ability to copre-
cipitate from cell lysates.
TRAF4 Promotes MEKK4 Activation of the JNK Pathway—Similar to previ-
ous findings, expression of TRAF4 weakly activates JNK, and MEKK4
expressed alone modestly activates JNK producing only a 3-fold increase in
JNK relative to basal (Fig. 4,A and B) (9, 10). However, coexpression of TRAF4
andMEKK4 resulted in synergistic activation of JNKproducing a 7-fold induc-
tion in phosphorylation of JNK (Fig. 4,A andB). JNK activation by coexpressed
TRAF4 and MEKK4 was markedly inhibited by the co-expression of
MEKK4K1361R (Fig. 4C). Additionally, the TRAF domain of TRAF4, the site
that binds MEKK4, was able to inhibit activation of JNK by MEKK4 (Fig. 4D).
Interestingly, TRAF4 does not promote MEKK4 activation of p38 (data not
shown). Furthermore, the TRAF domain of TRAF4 inhibits JNK, but not p38,
activation by MEKK4 indicating that TRAF4/MEKK4 complexes are specific
for JNK signaling (data not shown).
TRAF4 Increases MEKK4 Kinase Activity by Promoting Dimerization of
MEKK4—In vitro kinase assays demonstrate the ability of TRAF4 to increase
MEKK4 kinase activity. Coexpression of TRAF4 with MEKK4 resulted in a
2.2-fold stimulation of MEKK4 phosphorylation of purified His-MKK6 as
compared with expression of MEKK4 alone (Fig. 5A). One mechanism to
explain the ability of TRAF4 to increase MEKK4 kinase activity and MEKK4-
dependent JNK activation is through the oligomerization of MEKK4 by
TRAF4. This mechanism would also explain the ability of the kinase-inactive
MEKK4 to block activation of JNKbyTRAF4 andMEKK4. To test this hypoth-
esis, we examined the association ofwild-typeHA-taggedMEKK4with FLAG-
taggedMEKK4K1361R and found that wild-typeMEKK4 coprecipitated weakly
with the kinase-inactive MEKK4K1361R and that coprecipitation of wild-type
and kinase-inactive MEKK4K1361R is significantly enhanced by the presence of
TRAF4 (Fig. 5B). To further ascertain the ability of dimerization of MEKK4 to
promote signaling to JNK, we utilized a cell permeable synthetic dimerizer
AP20187. The kinase domain of MEKK4 was fused to two FKBP domains
containing a point mutation Phe363 Val (FV). AP20187 binds to FV with
1000 greater affinity than for endogenous FKBP (11). Cells expressing HA-
JNK alone displayed aminimal response to AP20187 (Fig. 5C). The addition of
the chemical dimerizer AP20187 to cells expressing both HA-FV-MEKK4 and
HA-JNK resulted in significant induction of JNK activation as measured by in
vitro phosphorylation ofGST-c-Jun byHA-JNK (Fig. 5C). Together, these data
demonstrate the ability of TRAF4 to induce the oligomerization of MEKK4
and promote MEKK4 activation and show that dimerization is sufficient to
induce MEKK4-dependent JNK activation.
Cumulatively, our results show that the TRAF domain of TRAF4 associates
with the kinase domain of MEKK4 and promotes MEKK4 activation and sig-
naling to JNK. The kinase-inactive MEKK4K1361R behaves as a dominant neg-
ative inhibitory mutant in TRAF4 complexes, inhibiting the activation of wild-
type MEKK4. Despite intensive investigation, upstream receptor pathways
that regulate TRAF4 have not been identified. Several lines of evidence suggest
that TRAF4 is an atypical member of the TRAF family. Unlike TRAF1 trans-
genics, and TRAF2, TRAF3, TRAF5 and TRAF6 knock-outs that each display
immune deficiencies, TRAF4 knock-outs have normal immune systems (3, 4,
15). Instead, TRAF4 knock-outs display severe open neural tube and skeletal
defects similar to theMEKK4 knock-out and theMEKK4K1361R knock-in (4, 5,
8). Other TRAFs have been shown to bind several members of the TNF recep-
FIGURE 3. Colocalization of TRAF4 and MEKK4 in the cytoplasm of COS-7 cells. COS-7
cells were transiently cotransfected with constructs encoding wild-type FLAG-tagged
MEKK4 and full-length TRAF4. Cells were immunostained with anti-FLAG (green) and
anti-TRAF4 (red) antibodies. Three independent examples are shown. Nuclei were
stained with DAPI. Bar equals 10 M.
FIGURE 4. Regulation of JNK by TRAF4 and
MEKK4. A, coexpression of MEKK4 with TRAF4
results in the synergistic activation of JNK. 293 cells
were cotransfected with constructs encoding HA-
JNK, TRAF4, and FLAG-MEKK4wt or FLAG-
MEKK4K1361R. HA-JNK was immunoprecipitated
with an anti-HA antibody and probed with an anti-
body to phospho-JNK. B, quantitation of JNK acti-
vation from A. P-JNK was normalized to total HA-
JNK. Data represent the mean  range from two
independent experiments. C, synergistic activa-
tion of JNK by MEKK4 and TRAF4 is blocked by co-
expression of MEKK4K1361R. 293 cells were cotrans-
fected with constructs encoding HA-JNK, TRAF4,
HA-MEKK4, and FLAG-MEKK4K1361R. HA-JNK was
immunoprecipitated with an anti-HA antibody
and probed with an antibody to phospho-JNK. D,
JNK activation by MEKK4 is inhibited by the TRAF
domain of TRAF4. Cells were cotransfected with
constructs encoding HA-JNK, FLAG-MEKK4, and
either full-length TRAF4 or the TRAF domain only
of TRAF4 and treated as described above.
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tor superfamily (3). In vitro binding experiments have shown that TRAF4
interacts weakly with the LTR and p75 nerve growth factor receptor but not
at all with TNFR1, TNFR2, Fas, or CD40 (16–18). Furthermore, TRAF4 shows
highest homology with the Drosophila TRAF (DTRAF1) with 45% amino acid
identity, suggesting that TRAF4 may represent an archaic member of the
TRAF family (1). Both DTRAF1 and TRAF4 have seven zinc fingers (as com-
pared with five in TRAF2, TRAF3, TRAF5, and TRAF6) and have a truncated
coiled-coil domain (1, 19). DTRAF1 has also been shown to activate JNK via a
mechanism involving binding to theMAP4KMisshapen (19). The similarity of
TRAF4 to DTRAF1 and the significant differences from other mammalian
TRAF family members suggest that regulation of TRAF4, the non-classical
mammalian TRAF, may be functionally different from other TRAF proteins
(6). Although we do not know the upstream stimuli for initiating TRAF4 acti-
vation of MEKK4 during development, we show that MEKK4 and TRAF4
associate in the developing embryo. The existence of an endogenous complex,
the coregulation of the JNK signaling pathway, and the overlapping pheno-
types of the TRAF4 knock-out and the MEKK4 knock-out and MEKK4K1361R
knock-in demonstrate the relevance of the TRAF4/MEKK4 interaction and
suggest that TRAF4 and MEKK4 are in a common pathway (4, 8, 20). TRAF4
effectors have been elusive, and our work defines MEKK4 as the first signaling
protein shown to be an effector for TRAF4 regulation of its kinase activity.
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FIGURE 5. Activation of MEKK4 by dimerization. A, TRAF4 promotes MEKK4 kinase
activity. FLAG-MEKK4 was cotransfected with either empty vector or TRAF4. Lysates were
immunoprecipitated with anti-FLAG antibody. Immunoprecipitates were incubated
with purified kinase-inactive His-MKK6. Phosphorylation of His-MKK6 was detected with
anti-phospho-MKK3/6 antibody. B, coprecipitation of HA-MEKK4wt with FLAG-
MEKK4K1361R is enhanced by TRAF4. 293 cells were cotransfected with HA-MEKK4wt and
FLAG-MEKK4K1361R in the absence or presence of TRAF4. Lysates were immunoprecipi-
tated with an anti-FLAG antibody and probed with an anti-HA antibody. C, dimerization
of MEKK4 by AP20187 increases MEKK4-dependent JNK activation. 293 cells were
cotransfected with HA-JNK and HA-FV-MEKK4 or empty vector. Cells were treated with
either vehicle alone (ethanol) or 20 nM AP20187 for the indicated times. Immunoprecipi-
tated HA-JNK was incubated with GST-c-Jun, and phosphorylation of substrate was
determined using a phospho-specific anti-c-Jun antibody. Total levels of HA-JNK and
HA-FV-MEKK4 were determined by immunoblotting with anti-HA antibody.
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